Ficha del valor · trimestre archivado
COLL
Collegium Pharmaceutical, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
14Tenedores rastreados
+1Δ titulares
12.36MAcciones mantenidas
$365.37MValor declarado
+1Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones -5.8% ·
nuevas posiciones netas +7.1%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 98 | +3 | 27.25M | $986.22M | +8 | −5 |
| Q1 2026 | 98 | -1 | 28.14M | $930.88M | +7 | −9 |
| Q4 2025 | 100 | 0 | 26.92M | $1.25B | +1 | — |
| Q3 2025 | 19 | +2 | 14.79M | $517.39M | +2 | — |
| Q2 2025 | 14 | +1 | 12.36M | $365.37M | +1 | — |
| Q1 2025 | 10 | -1 | 5.48M | $163.49M | — | −1 |
| Q4 2024 | 11 | -1 | 5.00M | $143.28M | — | −1 |
| Q3 2024 | 11 | -1 | 3.77M | $145.78M | — | −1 |
| Q2 2024 | 12 | — | 3.67M | $118.10M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 5.34M | — | $157.96M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 2.25M | — | $66.48M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 2.25M | — | $66.48M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 2.25M | — | $66.48M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 2.25M | — | $66.48M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasivo) | 2.25M | — | $66.48M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 1.52M | -5.9% | $44.98M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (pasivo) | 1.35M | -1.5% | $40.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (pasivo) | 780.24K | +1.9% | $23.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (pasivo) | 780.24K | +1.9% | $23.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 240.16K | -52.9% | $7.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 240.16K | -52.9% | $7.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Millennium Management ✦ | 223.97K | -65.4% | $6.62M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 203.93K | -21.9% | $6.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 203.93K | -21.9% | $6.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | Marshall Wace ✦ | 136.72K | Nuevo | $4.04M | 0.0% | New | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 136.72K | Nuevo | $4.04M | 0.0% | New | 1 | SEC ↗ |
| 33 | Marshall Wace ✦ | 136.72K | Nuevo | $4.04M | 0.0% | New | 1 | SEC ↗ |
| 34 | Wellington Management ✦ | 98.95K | +17.9% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 98.95K | +17.9% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 98.95K | +17.9% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 98.95K | +17.9% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 98.95K | +17.9% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 90.38K | -15.8% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 90.38K | -15.8% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 90.38K | -15.8% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 90.38K | -15.8% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 90.38K | -15.8% | $2.67M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 52.56K | — | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 52.56K | — | $1.55M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | T. Rowe Price ✦ | 36.26K | +5.0% | $1.07M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | Two Sigma Investments ✦ | 27.01K | -64.1% | $798,627 | 0.0% | ▼ Trim | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $4.04M | 0.0% |
| Marshall Wace | $4.04M | 0.0% |
| Marshall Wace | $4.04M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 5.10M acciones, $5.91M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API